Literature DB >> 18638598

Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy.

Sora Goetschmann1, Stefano Dibernardo, Hildegard Steinmann, Mladen Pavlovic, Nicole Sekarski, Jean-Pierre Pfammatter.   

Abstract

Atrial septal defects (ASDs) are typically asymptomatic in infancy and early childhood, and elective defect closure is usually performed at ages of 4 to 6 years. Severe pulmonary hypertension (PH) complicating an ASD is seen in adulthood and has only occasionally been reported in small children. A retrospective study was undertaken to evaluate the incidence of severe PH complicating an isolated ASD and requiring early surgical correction. During a 10-year period (1996 to 2006), 355 pediatric patients underwent treatment for isolated ASDs either surgically or by catheter intervention at 2 tertiary referral centers. Two hundred ninety-seven patients had secundum ASDs, and 58 had primum ASDs with mild to moderate mitral regurgitation. Eight infants were found with isolated ASDs (6 with secundum ASDs and 2 with primum ASDs) associated with significant PH, accounting for 2.2% of all patients with ASDs at the centers. These 8 infants had invasively measured pulmonary artery pressures of 50% to 100% of systemic pressure. They were operated in the first year of life and had complicated postoperative courses requiring specific treatment for PH for up to 16 weeks postoperatively. The ultimate outcomes in all 8 infants were good, with persistent normalization of pulmonary pressures during midterm follow-up of up to 60 months (median 28). All other patients with ASDs had normal pulmonary pressures, and the mean age at defect closure was significantly older, at 6.2 years for secundum ASDs and 3.2 years for primum ASDs. In conclusion, ASDs were rarely associated with significant PH in infancy but then required early surgery and were associated with excellent midterm outcomes in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18638598     DOI: 10.1016/j.amjcard.2008.03.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Prevalence of treatment, risk factors, and management of atrial septal defects in a pediatric Medicaid cohort.

Authors:  C Osborne Shuler; Avnish Tripathi; George B Black; Yong-Moon Mark Park; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2013-04-26       Impact factor: 1.655

2.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Pulmonary blood flow and pulmonary hypertension: Is the pulmonary circulation flowophobic or flowophilic?

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

4.  Small atrial septal defect associated with heart failure in an infant with a marginal left ventricle.

Authors:  Sandra D K Kingma; Lukas A Rammeloo; Vladimir Sojak; Jaroslav Hruda
Journal:  Clin Pract       Date:  2012-07-04

5.  Early Surgical Closure of Atrial Septal Defect Improves Clinical Status of Symptomatic Young Children with Underlying Pulmonary Abnormalities.

Authors:  Takeshi Tsuda; Ryan R Davies; Wolfgang Radtke; Christian Pizarro; Abdul M Bhat
Journal:  Pediatr Cardiol       Date:  2020-05-09       Impact factor: 1.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.